SAM
NKTR icon

Shell Asset Management’s Nektar Therapeutics NKTR Stock Holding History

Shell Asset Management’s Portfolio NKTR Stock Details NKTR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-724
Closed -$185K – 1480
2020
Q4 		$185K Buy
+724
New +$187K ﹤0.01% 1139
2019
Q4 		– Sell
-782
Closed -$214K – 1256
2019
Q3 		$214K Hold
782
– – ﹤0.01% 1117
2019
Q2 		$417K Sell
782
-37
-5% -$18.6K 0.01% 988
2019
Q1 		$413K Hold
819
– – 0.01% 985
2018
Q4 		$404K Buy
819
+97
+13% +$58.6K 0.01% 910
2018
Q3 		$661K Sell
722
-676
-48% -$577K 0.01% 873
2018
Q2 		$1.02M Buy
1,398
+47
+3% +$54.2K 0.02% 666
2018
Q1 		$2.15M Sell
1,351
-547
-29% -$705K 0.04% 380
2017
Q4 		$1.7M Sell
1,898
-1,509
-44% -$893K 0.03% 438
2017
Q3 		$1.23M Hold
3,407
– – 0.03% 521
2017
Q2 		$999K Sell
3,407
-191
-5% -$55.2K 0.02% 643
2017
Q1 		$1.27M Sell
3,598
-758
-17% -$170K 0.03% 516
2016
Q4 		$802K Hold
4,356
– – 0.02% 741
2016
Q3 		$1.12M Buy
4,356
+1,238
+40% +$319K 0.02% 599
2016
Q2 		$665K Hold
3,118
– – 0.02% 679
2016
Q1 		$643K Hold
3,118
– – 0.02% 623
2015
Q4 		$788K Hold
3,118
– – 0.02% 599
2015
Q3 		$564K Hold
3,118
– – 0.01% 753
2015
Q2 		$585K Hold
3,118
– – 0.01% 726
2015
Q1 		$514K Hold
3,118
– – 0.01% 769
2014
Q4 		$725K Hold
3,118
– – 0.01% 755
2014
Q3 		$564K Sell
3,118
-708
-19% -$135K 0.01% 779
2014
Q2 		$736K Hold
3,826
– – 0.01% 774
2014
Q1 		$696K Sell
3,826
-1,347
-26% -$267K 0.01% 760
2013
Q4 		$881K Hold
5,173
– – 0.02% 721
2013
Q3 		$811K Hold
5,173
– – 0.01% 728
2013
Q2 		$896K Buy
+5,173
New +$793K 0.02% 709

Other funds holding NKTR

Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

Shell Asset Management's NKTR Position: Q1 2021 in Review

Shell Asset Management sold out of Nektar Therapeutics (NKTR) in Q1 2021, closing a stake of 724 shares — an estimated $185K sold.

Shell Asset Management first reported a position in NKTR in Q2 2013 and held it in 27 quarters. The position peaked at $2.15M in Q1 2018. 235 funds tracked by Wall St. Rank hold NKTR as of Q1 2021.

  • Shell Asset Management reported no remaining Nektar Therapeutics position as of Q1 2021 after selling out during the quarter.
  • Shell Asset Management sold 724 Nektar Therapeutics shares in Q1 2021, an estimated $185K.
  • Shell Asset Management first reported a position in Nektar Therapeutics in Q2 2013 and held it in 27 quarters.
  • Shell Asset Management's Nektar Therapeutics position peaked at $2.15M in Q1 2018.
  • 235 funds tracked by Wall St. Rank held Nektar Therapeutics as of Q1 2021.

Based on Shell Asset Management's 13F filing for Q1 2021, filed 10 May 2021.